![]() OSR Holdings OSR Holdings (formerly known as Bellevue Life Sciences Acquisition) is a company focused on healthcare innovation. | ![]() Kineta Kineta is a biotechnology company that is engaged in the discovery and development of antiviral therapies and immune-modulating drugs for the treatment of RNA viruses that include hepatitis C, influenza, west nile virus, and common cold. | ![]() Tactile Medical Tactile Medical is advancing the standard of care in treating chronic diseases at home. | ![]() Petra Pharma Petra Pharma is a drug development company focused on therapies for serious medical conditions such as cancer and metabolic diseases. | ![]() NeuSpera Medical NeuSpera Medical is a provider of bioelectric medicine to treat many chronic and debilitating diseases, developing ultra miniaturized medicines. | |
Founding Date | Founding Date 2019 | Founding Date 2008 | Founding Date 2006 | Founding Date 2016 | Founding Date 2013 |
Type | Type Public | Type Public | Type Public | Type Subsidiary | Type Private |
Tags | |||||
Locations | Locations Bellevue, US HQ | Locations Seattle, US HQ | Locations Minneapolis, US HQ | Locations New York, US HQ | Locations San Jose, US HQ |
Employees | Employees 5 | Employees 353% increase | Employees 62926% increase | Employees 20 | Employees 432% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 7 m | Valuation ($) 346.8 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $2.9m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $329.5m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods $2.3m (FY, 2025) | Cost of goods N/A | Cost of goods $79.4m (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $592.9k (FY, 2025) | Gross profit N/A | Gross profit $250.1m (FY, 2025) | Gross profit N/A | Gross profit N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 52.2m | Total funding raised $ 23.2m | Total funding raised $ 48m | Total funding raised $ 111.9m |

Kineta is a biotechnology company that is engaged in the discovery and development of antiviral therapies and immune-modulating drugs for the treatment of RNA viruses that include hepatitis C, influenza, west nile virus, and common cold.
View company
Tactile Medical is advancing the standard of care in treating chronic diseases at home.
View company
Petra Pharma is a drug development company focused on therapies for serious medical conditions such as cancer and metabolic diseases.
View company
NeuSpera Medical is a provider of bioelectric medicine to treat many chronic and debilitating diseases, developing ultra miniaturized medicines.
View company